Form S-1/A CATALYST BIOSCIENCES,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
Go back to Form S-1/A CATALYST BIOSCIENCES,
April 7, 2017 8:40 AM EDT
Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced the pricing of an underwritten public offering of units for gross proceeds of $18 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Catalyst.
The offering is comprised of Class A Units, priced at a public offering price of $5.00 per unit, with each unit consisting of one share of common stock and a five-year warrant (each, a warrant) to purchase one-half share of common stock with an... More
April 7, 2017 6:46 AM EDT
Catalyst Biosciences (NASDAQ: CBIO) was set to open sharply lower Friday morning following an effective notice from the SEC regarding its recent S-1.
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549Notice of EffectivenessEffectiveness Date:April 6, 2017 5:00 P.M.Form:S-1CIK:
0001124105Company Name:CATALYST BIOSCIENCES, INC.File Number:
333-216663...
More
